Navigation Links
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Date:6/23/2011

ulate in the blood after each meal. When such particles, called chylomicrons, accumulate in the blood, they may obstruct small blood vessels. Excess chylomicrons result in recurrent and severe acute inflammation of the pancreas, called pancreatitis, the most debilitating complication of LPLD. Glybera® has orphan drug status in the EU and US.

About Amsterdam Molecular Therapeutics

AMT is a world leader in the development of human gene based therapies. In addition to Glybera, AMT has a product pipeline of several gene therapy products in development for hemophilia B, Duchenne muscular dystrophy, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate probably the world's first stable and scalable AAV manufacturing platform. This proprietary platform can be applied to a large number of rare (orphan) diseases caused by one faulty gene and allows AMT to pursue its strategy of focusing on this sector of the industry.  AMT was founded in 1998 and is based in Amsterdam. Further information can be found at http://www.amtbiopharma.com.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy,""expects,"" plans,""anticipates,""believes, ""will,""continues," "estimates,""intends,"" projects,""goals,""targets " and other words of similar meaning are intended to identify such f
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
2. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
3. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
4. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
5. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
6. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
7. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
8. The World Leader in Molecular Breast Imaging to Premiere Largest Detector in the Industry
9. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
10. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
11. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... reported financial results for the first fiscal quarter ended ... , Revenues of $47.5 million, up 10% over last ... up 50% over last year,s comparable quarter. ... million, up 20% over last year,s comparable quarter. ...
(Date:7/24/2014)... VIEW, Calif. , July 24, 2014  IRIDEX ... it will release its second quarter 2014 financial results ... 2014. In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
(Date:7/24/2014)... , July 24, 2014 Omnicell, ... provider of medication and supply management solutions and ... call Thursday, July 31, to discuss the Company,s ... Omnicell Second Quarter 2014 earnings conference call and ... PTWho:  , Randall Lipps, chairman, president and chief ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... Biosciences, a privately held company leading the development of ... McDonald, MBA, Senior Vice President and Chief Business Officer, ... will highlight new and innovative cardiovascular drug therapies at ... discussion will be held at the New York Palace ...
... Inc., today announced the expansion of its Nutraficient®, ... high-productivity systems designed specifically for use on food ... European Commission Directive (2010/69/EU), already adopted in the ... certain food supplement products.  The additives now allowed ...
Cached Medicine Technology:Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 2Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 3
(Date:7/25/2014)... Youngstown, Ohio (PRWEB) July 25, 2014 ... processed foods? How to know? , Read the labels! ... labels and determine how it relates to health during ... 12:30 p.m. Aug. 1 at Humility House, 755 Ohltown ... Lackey will lead an informational discussion and answer questions. ...
(Date:7/25/2014)... July 25, 2014 As reported by Wood ... Deaths Increase (7/20), Michigan has seen a nearly 500-person increase ... While the count was 271 between 1999 and 2002, the ... Agents believe that, like other states, drug users in Michigan ... via prescription pills. He compared the price of both substances, ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The Little ... Fun Fest on Sunday, July 27 at Discovery Green ... include Memorial, Copperfield, Katy, Pearland, Friendswood, Spring, The Woodlands, ... The Heights. , “We’re thrilled to be attending ... said Heather Belcher who owns the Sugarland-Missouri City location. ...
(Date:7/25/2014)... 25, 2014 Art of Facial Surgery has ... those in Toronto who are looking for minor touch-ups to ... done by the American Academy of Facial Plastic and Reconstructive ... in facial plastic surgery showed a surprising increase between 2012 ... percent, while hair transplants increased by 7 percent and eyelid ...
(Date:7/25/2014)... Washington, NY (PRWEB) July 25, 2014 ... protecting the rights of consumers comments on a recent ... widow of a smoker $23.6 billion in punitive damages. ... manufactures Kool brand cigarettes. The case is Cynthia Robinson ... 2008 in the Florida First Circuit Court, Escambia County, ...
Breaking Medicine News(10 mins):Health News:Learn to Decipher Food Labels at Humility House 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3
... Software, Inc. today,announced the worldwide launch of iFastrack, ... software for reducing business,risk by tracking insurance certificates ... to manage their risk from,uninsured contractors, vendors or ... proof of insurance at the onset of a ...
... Pa., Aug. 6 The Quigley,Corporation (Nasdaq: QGLY ... to succeed George J. Longo, who will be retiring ... Chief Financial Officer and as a,member of the Board ... and has served in management positions including,Corporate Controller of ...
... Saddleback Church Hosts International AIDS Conference Satellite Session on ... the Partnership of Government, Business & the Church, ... and executive director of the Saddleback HIV/AIDS Initiative,moderated a ... experts; and Saddleback HIV/AIDS Initiative directors; along with,her husband, ...
... software for physician offices, hospitalists and medical billing services, kicked-off ... ... Orlando, FL (PRWEB) August 6, 2008 ... [medical billing software] for physician offices, hospitalists and medical billing ...
... Hospitalized Patient, SCHAFFHAUSEN, Switzerland, Aug. 6 ... to treat,heart failure, announced first use of the ... and Dr. Fabrizio Oliva at Ospedale Niguarda Ca,Granda-Milano, ... to,provide the latest medical technology to treat patients., ...
... ATSI ), manufacturer and marketer of state-of-the-art ... at the Canaccord,Adams 28th Annual Global Growth Conference ... and CEO of ATS Medical, will present at,2:30 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), Attendance at ...
Cached Medicine News:Health News:GG-One Software Announces iFastrack to Help Avoid Insurance Disasters 2Health News:The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director 2Health News:Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: 2Health News:Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: 3Health News:Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: 4Health News:CollaborateMD Launches New Value-Added Reseller (VAR) Program 2Health News:Ospedale Niguarda Ca' Granda-Milano Adopts Latest Technology to Treat Patients with Heart Failure 2Health News:ATS Medical to Participate at the 28th Annual Canaccord Adams Global Growth Conference 2
Aplio was designed for intuitive operation so you can get the results you are looking for quickly and easily. From customizable measurement packages to an ergonomic platform design, Aplio was built m...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Fludeoxyglucose F 18 Injection:, The PETNET SafetyNET: 99% On-Time Delivery of MetaTrace FDG , Largest Cyclotron - Equipped Radiopharmacy Network , 39 MetaTrace FDG producing sites , Customi...
... The AB Holter, a ... system, provides sophisticated,ambulatory ECG analysis ... Windows environment.,Designed to use Windows ... the system allows,the option of ...
Medicine Products: